Promoting Use of Effective Early Intervention Programs

促进有效的早期干预计划的使用

基本信息

  • 批准号:
    7670012
  • 负责人:
  • 金额:
    $ 39.92万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-03-01 至 2011-07-31
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): There is now strong scientific support for the widespread implementation of proven, effective early intervention programs for young children with, or at risk for, developmental disability. However, in practice, programs that lack demonstrated effectiveness are often implemented, undermining the impact of early intervention. The long-term goal of the current project is to increase the likelihood that children ages 0-5 years with or at risk for developmental disability receive effective intervention services. To this end, the specific aims of the proposed Phase II work will be to fully develop and make ready for commercial dissemination three products for which prototypes already exist from R&D completed in Phase I and from prior successful Sociometrics products. The central product is the Early Intervention Program Archive to Reduce Developmental Disability (EIPARDD), which will consist of complete replication kits of all necessary materials (e.g., manuals, workbooks) to implement and evaluate an empirically-supported intervention. Interventions included in EIPARDD were identified through a comprehensive scientific literature search and extensive evaluation by an independent Expert Panel in Phase I. Access to 12 empirically-supported intervention programs was secured in Phase I, and a prototype kit for one EIPARDD program was constructed and favorably evaluated by consumers. The specific aim for Phase II is to make all materials for each program in EIPARDD ready for commercial distribution by the end of the grant period. The other two products enhance the use of EIPARDD by (1) facilitating the selection of the appropriate empirically-supported intervention program for a given need (including those not available as replication kits), through an online Early Intervention Program Selection Resource; and (2) promoting program fidelity and evaluation through a set of Early Intervention Program Implementation and Evaluation Tutorials that offer generalized and program- tailored implementation and evaluation information in online and USB flash drive formats. Specific Phase II aims are to make these two ancillary products ready for commercial distribution by the end of the grant period. Technical usability testing and consumer feedback will be used extensively throughout the process to ensure that all final products meet the needs of early intervention professionals. In addition, a mixed-method research study will be conducted to investigate the fidelity of implementing effective early intervention programs in new sites. The replication kits will be marketed to early intervention decision-makers at local, state and regional levels. The commercial market for these products is substantial with over 102,000 professionals working in early intervention under the federal Individuals with Disabilities Education Act (IDEA) Parts B and C, serving nearly one million children ages 0-5 years. PUBLIC HEALTH RELEVANCE: The EIPARDD and its associated products will promote public health in two key ways. It will: (1) offer more young children with or at risk of developmental delay and their families efficacious early intervention services, by providing EI decision-makers with an array of efficacious EI programs from which to easily and affordably select, implement, adapt, and evaluate their efforts as they deliver EI services, and (2) prepare current and aspiring EI specialists about effective EI programs for children with or at risk of developmental delays by offering early childhood faculty and trainers accessible and interactive research-based information for use in pre-service preparation, staff orientation, staff training. More widespread use, adaptation, and evaluation of efficacious EI programs for children with or at risk for developmental delay, and more highly skilled EI professionals, should be the result.
描述(由申请人提供):现在有强有力的科学支持,广泛实施经过验证的、有效的早期干预计划,用于患有或有发展障碍风险的幼儿。然而,在实践中,缺乏被证明有效的计划经常被实施,削弱了早期干预的影响。目前项目的长期目标是增加0-5岁有发育障碍或有发育障碍风险的儿童获得有效干预服务的可能性。为此,拟议的第二阶段工作的具体目标将是充分开发和准备好商业传播的三种产品,这些产品的原型已经存在于第一阶段完成的研发中,并来自以前成功的社会计量产品。核心产品是减少发育障碍的早期干预计划档案(EIPARDD),它将包括所有必要材料(如手册、工作簿)的完整复制工具包,以实施和评估经验性干预。在第一阶段,通过全面的科学文献搜索和独立专家小组的广泛评估,确定了EIPARDD中包含的干预措施。在第一阶段,确保了12个经验性支持的干预计划的使用,并为一个EIPARDD计划构建了原型试剂盒,并得到了消费者的积极评价。第二阶段的具体目标是在授权期结束前使EIPARDD中每个项目的所有材料都准备好进行商业分发。其他两款产品通过以下方式加强了EIPARDD的使用:(1)通过在线早期干预计划选择资源,促进为特定需求选择适当的经验性支持的干预计划(包括那些未作为复制工具包提供的干预计划);以及(2)通过一套早期干预计划实施和评估教程,促进计划的保真度和评估,这些教程以在线和USB闪存驱动器格式提供通用的和针对计划定制的实施和评估信息。第二阶段的具体目标是在授权期结束前使这两种辅助产品准备好进行商业分销。在整个过程中,将广泛使用技术可用性测试和消费者反馈,以确保所有最终产品满足早期干预专业人员的需求。此外,将进行一项混合方法的研究,以调查在新地点实施有效的早期干预计划的保真度。复制试剂盒将向地方、州和地区各级的早期干预决策者销售。这些产品的商业市场很大,根据联邦残疾人教育法(IDEA)B和C部分,有超过102,000名专业人员从事早期干预工作,为近100万0-5岁儿童提供服务。公共卫生相关性:EIPARDD及其相关产品将在两个关键方面促进公共卫生。它将:(1)为更多有发育迟缓或有发育迟缓风险的幼儿及其家人提供有效的早期干预服务,为教育投资决策者提供一系列有效的教育投资计划,以便在提供教育投资服务时轻松、实惠地选择、实施、调整和评估他们所做的努力,以及(2)通过为幼儿教师和培训人员提供可访问和互动的基于研究的信息,使其能够在职前准备、工作人员定向和员工培训中使用,从而培养现有的和有抱负的教育投资专家,为有发展迟缓或有发育迟缓风险的儿童提供有效的教育投资计划。结果应该是为有发育迟缓或有发育迟缓风险的儿童和更高技能的EI专业人员更广泛地使用、适应和评估有效的EI计划。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Luba Botcheva其他文献

Luba Botcheva的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Luba Botcheva', 18)}}的其他基金

Teen Bullying Prevention across Place and Digital Space: The TOTAL Approach
跨场所和数字空间的青少年欺凌预防:总体方法
  • 批准号:
    8253090
  • 财政年份:
    2012
  • 资助金额:
    $ 39.92万
  • 项目类别:

相似国自然基金

靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 批准年份:
    2025
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
  • 批准年份:
    2024
  • 资助金额:
    0 万元
  • 项目类别:
    面上项目
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
  • 批准号:
    2023JJ50274
  • 批准年份:
    2023
  • 资助金额:
    0.0 万元
  • 项目类别:
    省市级项目
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
  • 批准号:
  • 批准年份:
    2022
  • 资助金额:
    33 万元
  • 项目类别:
    地区科学基金项目
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
  • 批准号:
    n/a
  • 批准年份:
    2022
  • 资助金额:
    10.0 万元
  • 项目类别:
    省市级项目
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
  • 批准号:
    81973577
  • 批准年份:
    2019
  • 资助金额:
    55.0 万元
  • 项目类别:
    面上项目
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
  • 批准号:
    81602908
  • 批准年份:
    2016
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目
高血糖激活滑膜AGE-RAGE-PKC轴致骨关节炎易感的机制研究
  • 批准号:
    81501928
  • 批准年份:
    2015
  • 资助金额:
    18.0 万元
  • 项目类别:
    青年科学基金项目

相似海外基金

PROTEMO: Emotional Dynamics Of Protective Policies In An Age Of Insecurity
PROTEMO:不安全时代保护政​​策的情绪动态
  • 批准号:
    10108433
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    EU-Funded
The role of dietary and blood proteins in the prevention and development of major age-related diseases
膳食和血液蛋白在预防和发展主要与年龄相关的疾病中的作用
  • 批准号:
    MR/X032809/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Fellowship
Atomic Anxiety in the New Nuclear Age: How Can Arms Control and Disarmament Reduce the Risk of Nuclear War?
新核时代的原子焦虑:军控与裁军如何降低核战争风险?
  • 批准号:
    MR/X034690/1
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Fellowship
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341426
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Continuing Grant
Collaborative Research: Resolving the LGM ventilation age conundrum: New radiocarbon records from high sedimentation rate sites in the deep western Pacific
合作研究:解决LGM通风年龄难题:西太平洋深部高沉降率地点的新放射性碳记录
  • 批准号:
    2341424
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Continuing Grant
Doctoral Dissertation Research: Effects of age of acquisition in emerging sign languages
博士论文研究:新兴手语习得年龄的影响
  • 批准号:
    2335955
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Standard Grant
The economics of (mis)information in the age of social media
社交媒体时代(错误)信息的经济学
  • 批准号:
    DP240103257
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Discovery Projects
How age & sex impact the transcriptional control of mammalian muscle growth
你多大
  • 批准号:
    DP240100408
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Discovery Projects
Supporting teachers and teaching in the age of Artificial Intelligence
支持人工智能时代的教师和教学
  • 批准号:
    DP240100111
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Discovery Projects
Enhancing Wahkohtowin (Kinship beyond the immediate family) Community-based models of care to reach and support Indigenous and racialized women of reproductive age and pregnant women in Canada for the prevention of congenital syphilis
加强 Wahkohtowin(直系亲属以外的亲属关系)以社区为基础的护理模式,以接触和支持加拿大的土著和种族育龄妇女以及孕妇,预防先天梅毒
  • 批准号:
    502786
  • 财政年份:
    2024
  • 资助金额:
    $ 39.92万
  • 项目类别:
    Directed Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了